Skip to main content

Published locations for FDA expands fingolimod's indications to treat relapsing MS in pediatric patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands fingolimod's indications to treat relapsing MS in pediatric patients

User login

  • Reset your password
  • /content/fda-expands-fingolimods-indications-treat-relapsing-ms-pediatric-patients
  • /clinicianreviews/article/165511/multiple-sclerosis/fda-expands-fingolimods-indications-treat
  • /familypracticenews/article/165511/multiple-sclerosis/fda-expands-fingolimods-indications-treat
  • /pediatricnews/article/165511/multiple-sclerosis/fda-expands-fingolimods-indications-treat-relapsing
  • /pediatrics/article/165511/multiple-sclerosis/fda-expands-fingolimods-indications-treat-relapsing-ms
  • /neurology/article/165511/multiple-sclerosis/fda-expands-fingolimods-indications-treat-relapsing-ms
  • /familymedicine/article/165511/multiple-sclerosis/fda-expands-fingolimods-indications-treat-relapsing
  • /clinicalneurologynews/article/165511/multiple-sclerosis/fda-expands-fingolimods-indications-treat